Pfizer, Moderna boost prices for COVID-19 vaccine, but we always knew the plandemic was going to be a huge cash cow for Big Pharma


(Planet Today) Well, that didn’t take long.

Giving just a few pharmaceutical companies complete monopoly over the COVID-19 vaccine, which world leaders are pushing on billions and billions of people, wasn’t enough, apparently, because two of them just raised their prices for their shots.

(Article by JD Heyes republished from NaturalNews.com)

Reuters reports:

Pfizer Inc and Moderna Inc have raised the prices of their COVID-19 vaccines in their latest European Union supply contracts, the Financial Times reported.

The new price for the Pfizer shot was 19.50 euros ($23.15) against 15.50 euros previously, the newspaper said, citing portions of the contracts seen.

The price of a Moderna vaccine was $25.50 a dose, the contracts show, up from about 19 euros in the first procurement deal but lower than the previously agreed $28.50 because the order had grown, the report said, citing one official close to the matter.

That’s Europe, mind you, but the price increases are coming to the United States as well, or more accurately, to U.S. taxpayers since ‘the government’ is buying them.

But it was obvious all along what was going to happen here: Given the opportunity for vaccine monopolies, the plan among the Big Pharma companies that developed them first was little more than a ‘get rich quick’ scheme, as Sharon Lerner of The Intercept noted at the beginning of the pandemic — March 2020.

“As the new coronavirus spreads illness, death, and catastrophe around the world, virtually no economic sector has been spared from harm. Yet amid the mayhem from the global pandemic, one industry is not only surviving, it is profiting handsomely,” she wrote, citing the pharmaceutical industry.

Others saw the money tsunami for Big Pharma rolling in as well.

“Pharmaceutical companies view Covid-19 as a once-in-a-lifetime business opportunity,” Gerald Posner, author of “Pharma: Greed, Lies, and the Poisoning of America,” told Lerner.

“The world needs pharmaceutical products, of course,” he claimed. “For the new coronavirus outbreak, in particular, we need treatments and vaccines and, in the U.S., tests. Dozens of companies are now vying to make them.

“They’re all in that race,” Posner added, noting that the then-potential payoffs were going to be monumental (and indeed they have been — and are about to get higher, thanks to the new price increases).

The pandemic “will potentially be a blockbuster for the industry in terms of sales and profits,” he told Lerner, adding that “the worse the pandemic gets, the higher their eventual profit.”

Delta variant, anyone? Endless variants next? Perpetual need for ‘COVID’ vaccines and boosters, like an over-hyped, much more expensive version of the annual flu vaccine clown show?

You bet. Because new billionaires have been created.